2.1.1.321: type III protein arginine methyltransferase
This is an abbreviated version!
For detailed information about type III protein arginine methyltransferase, go to the full flat file.
Word Map on EC 2.1.1.321
-
2.1.1.321
-
prmt7
-
histone
-
monomethylation
-
metastasis
-
monomethylarginine
-
dimethylarginine
-
nanog
-
adomet
-
medicine
- 2.1.1.321
- prmt7
- histone
-
monomethylation
- metastasis
-
monomethylarginine
- dimethylarginine
-
nanog
- adomet
- medicine
Reaction
Synonyms
EC 2.1.1.124, EC 2.1.1.125, EC 2.1.1.126, EC 2.1.1.23, PRMT-7, PRMT7, protein arginine methyltransferase 7
ECTree
Advanced search results
Disease
Disease on EC 2.1.1.321 - type III protein arginine methyltransferase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Breast Neoplasms
Automethylation of protein arginine methyltransferase 7 and its impact on breast cancer progression.
Breast Neoplasms
PRMT7 contributes to the metastasis phenotype in human non-small-cell lung cancer cells possibly through the interaction with HSPA5 and EEF2.
Breast Neoplasms
Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression.
Neoplasm Metastasis
Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets RXR sites in lysine- and arginine-rich regions.
Neoplasm Metastasis
PRMT7 contributes to the metastasis phenotype in human non-small-cell lung cancer cells possibly through the interaction with HSPA5 and EEF2.
Neoplasm Metastasis
Structural insight into arginine methylation by the mouse protein arginine methyltransferase 7: a zinc finger freezes the mimic of the dimeric state into a single active site.
Neoplasm Metastasis
Substrate specificity of human protein arginine methyltransferase 7 (PRMT7): the importance of acidic residues in the double E loop.
html completed